UnitedHealth Group Incorporated $UNH Holdings Trimmed by Aljian Capital Management LLC

Aljian Capital Management LLC lowered its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 9.3% in the first quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 12,146 shares of the healthcare conglomerate’s stock after selling 1,239 shares during the period. UnitedHealth Group makes up 0.7% of Aljian Capital Management LLC’s portfolio, making the stock its 21st biggest position. Aljian Capital Management LLC’s holdings in UnitedHealth Group were worth $3,286,000 at the end of the most recent quarter.

Several other hedge funds have also recently bought and sold shares of UNH. Norges Bank acquired a new position in shares of UnitedHealth Group in the 4th quarter valued at about $4,376,167,000. Capital Research Global Investors lifted its position in UnitedHealth Group by 126.9% in the 3rd quarter. Capital Research Global Investors now owns 13,042,049 shares of the healthcare conglomerate’s stock worth $4,503,419,000 after buying an additional 7,293,009 shares in the last quarter. Capital World Investors grew its holdings in shares of UnitedHealth Group by 18.8% during the 3rd quarter. Capital World Investors now owns 21,766,922 shares of the healthcare conglomerate’s stock valued at $7,516,107,000 after acquiring an additional 3,439,182 shares in the last quarter. T. Rowe Price Investment Management Inc. raised its holdings in shares of UnitedHealth Group by 141.9% during the fourth quarter. T. Rowe Price Investment Management Inc. now owns 4,109,029 shares of the healthcare conglomerate’s stock worth $1,356,432,000 after acquiring an additional 2,410,128 shares in the last quarter. Finally, Cardano Risk Management B.V. increased its position in UnitedHealth Group by 864.4% in the 4th quarter. Cardano Risk Management B.V. now owns 2,523,700 shares of the healthcare conglomerate’s stock worth $833,099,000 after purchasing an additional 2,262,006 shares during the last quarter. 87.86% of the stock is owned by hedge funds and other institutional investors.

UnitedHealth Group Stock Up 2.4%

Shares of UNH stock opened at $428.00 on Wednesday. The stock has a 50 day moving average of $395.60 and a 200-day moving average of $336.86. The firm has a market cap of $388.68 billion, a PE ratio of 32.33, a price-to-earnings-growth ratio of 1.68 and a beta of 0.62. The company has a quick ratio of 0.80, a current ratio of 0.80 and a debt-to-equity ratio of 0.69. UnitedHealth Group Incorporated has a 12 month low of $234.60 and a 12 month high of $430.20.

UnitedHealth Group (NYSE:UNH) last released its earnings results on Tuesday, April 21st. The healthcare conglomerate reported $7.23 EPS for the quarter, beating the consensus estimate of $6.76 by $0.47. The firm had revenue of $111.65 billion during the quarter, compared to analysts’ expectations of $109.84 billion. UnitedHealth Group had a net margin of 2.68% and a return on equity of 14.65%. The business’s quarterly revenue was up 2.0% compared to the same quarter last year. During the same period in the prior year, the company earned $7.20 EPS. UnitedHealth Group has set its FY 2026 guidance at 18.250- EPS. On average, equities analysts predict that UnitedHealth Group Incorporated will post 18.32 EPS for the current year.

UnitedHealth Group Increases Dividend

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, June 23rd. Shareholders of record on Monday, June 15th were given a $2.32 dividend. The ex-dividend date was Monday, June 15th. This represents a $9.28 dividend on an annualized basis and a dividend yield of 2.2%. This is an increase from UnitedHealth Group’s previous quarterly dividend of $2.21. UnitedHealth Group’s dividend payout ratio is 70.09%.

Analyst Ratings Changes

Several equities research analysts have recently issued reports on the company. Sanford C. Bernstein reiterated an “outperform” rating on shares of UnitedHealth Group in a report on Tuesday, June 23rd. JPMorgan Chase & Co. lifted their target price on shares of UnitedHealth Group from $420.00 to $466.00 and gave the company an “overweight” rating in a research note on Monday, June 8th. Leerink Partners raised their price target on shares of UnitedHealth Group from $400.00 to $462.00 and gave the company an “outperform” rating in a report on Wednesday, June 17th. Morgan Stanley upped their price objective on shares of UnitedHealth Group from $453.00 to $468.00 and gave the stock an “overweight” rating in a report on Tuesday, June 30th. Finally, Cantor Fitzgerald reaffirmed an “overweight” rating on shares of UnitedHealth Group in a research report on Thursday, June 11th. One investment analyst has rated the stock with a Strong Buy rating, twenty-one have assigned a Buy rating, four have given a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $414.75.

Insider Activity

In related news, CEO Patrick Hugh Conway sold 800 shares of the company’s stock in a transaction on Thursday, April 23rd. The stock was sold at an average price of $355.00, for a total value of $284,000.00. Following the completion of the transaction, the chief executive officer directly owned 17,805 shares in the company, valued at approximately $6,320,775. This represents a 4.30% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Corporate insiders own 0.28% of the company’s stock.

UnitedHealth Group News Summary

Here are the key news stories impacting UnitedHealth Group this week:

• Positive Sentiment: An external audit of UnitedHealth’s HouseCalls senior home visits found that nearly 97% of diagnoses were supported by patients’ medical records, easing concerns that the unit was inflating diagnoses to increase Medicare reimbursements. Reuters article
• Positive Sentiment: UnitedHealth said the audit helps validate its home-health practices, which could reduce regulatory and reputational risk around Medicare Advantage reimbursement concerns. Healthcare Dive article
• Positive Sentiment: The stock has been one of the stronger large-cap healthcare names this year, with coverage noting a solid first-half rebound and signs that management is addressing prior problem areas. Motley Fool article
• Positive Sentiment: UnitedHealth is also being viewed more favorably for its strategy shift toward profitability, with improving margins, stronger earnings, and Optum expansion supporting the turnaround case. Yahoo Finance article
• Positive Sentiment: The company expanded insurance coverage for Guardant Health’s Shield blood test for colorectal cancer screening in adults 45 and older, reinforcing its role in broadening access to emerging medical technologies. Yahoo Finance article
• Neutral Sentiment: HSBC raised its price target on UNH to $380 while keeping a hold rating, which is constructive but still implies the stock may be trading above the firm’s view of fair value. Benzinga article
• Neutral Sentiment: Some recent market commentary still highlighted a prior pullback in the shares, suggesting investors are watching whether the rebound is durable. Yahoo Finance article

UnitedHealth Group Company Profile

UnitedHealth Group Inc is a diversified health care company headquartered in Minnetonka, Minnesota, that operates two primary business platforms: UnitedHealthcare and Optum. Founded in 1977, the company provides a broad range of health benefits and health care services to individuals, employers, governmental entities and other organizations. Its operations span commercial employer-sponsored plans, individual and Medicare and Medicaid programs, and services for customers and health systems in the United States and selected international markets.

UnitedHealthcare is the company’s benefits business, administering health plans and networks, managing provider relationships, and offering coverage products for employers, individuals, and government-sponsored programs.